Literature DB >> 29025680

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29025680     DOI： 10.1016/j.ajo.2017.09.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  5 in total

1.  Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-02       Impact factor: 3.117

2.  Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-04       Impact factor: 3.117

3.  Comment on "Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography".

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

4.  Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.

Authors:  Glenn Yiu; R Joel Welch; Yinwen Wang; Zhe Wang; Pin-Wen Wang; Zdenka Haskova
Journal:  Ophthalmol Retina       Date:  2019-08-28

5.  Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant.

Authors:  Verónica Castro-Navarro; Clara Monferrer-Adsuara; Catalina Navarro-Palop; Javier Montero-Hernández; Enrique Cervera-Taulet
Journal:  BMC Ophthalmol       Date:  2022-04-26       Impact factor: 2.209
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.